Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Discovery to develop aerosolized formulations of Surfaxin

Feb. 28, 2000

New respiratory therapeutics from Zambon act as phosphodiesterase inhibitors

Feb. 28, 2000

PathoGenesis announces approval, distribution agreement for TOBI

Feb. 25, 2000

New treatment for COPD from Ono to enter clinical trials soon

Feb. 24, 2000

Life-saving treatment for pulmonary hypertension in newborn babies featured in NEJM

Feb. 23, 2000

Development of cystic fibrosis therapy advances at SciClone

Feb. 17, 2000

Antiallergic agents from SB act as CCR3 receptor antagonists

Feb. 16, 2000

Neurokinin antagonists in early development at AstraZeneca

Feb. 15, 2000

First market introduction for INOmax

Feb. 15, 2000

Synthesis and use of new PKC inhibitors in development at AstraZeneca

Feb. 15, 2000

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...